Gilead Sciences develops transformative medicines for people facing life-threatening diseases. With a portfolio spanning virology, oncology and inflammation, the company brings over three decades of scientific rigour to breakthrough therapies that change outcomes for patients worldwide. Operating across 35 countries, Gilead combines research excellence with a commitment to health equity. Beyond discovering medicines, Gilead addresses barriers to care through licensing programmes, local partnerships and philanthropic initiatives that expand treatment access and support public health infrastructure in underserved regions. Every therapy represents scientific progress and a step towards a healthier, more equitable world.
17000
Team Members
1987
Founded
Pharma
Sector
Hybrid
Work Environment
A world where everyone, regardless of geography or circumstance, has access to the medicines and care needed to live a full, healthy life free from the burden of preventable and treatable disease
At Gilead, our mission is to discover, develop and deliver innovative therapeutics for people with life-threatening diseases